TB-500 | Peptide Reference Material
RESEARCH PEPTIDE

TB-500 | Peptide Reference Material

Thymosin Beta-4 Fragment — Research Peptide
$39.00
TB-500 laboratory peptide reference material. Sequence, molecular identity, and any relationship to full-length thymosin beta-4 remain under scientific review. Research use only; not for human or veterinary use.
✓ Identity Verified
✓ Batch Documentation
✓ QR Lot Verification
✓ Research Use Only
✓ U.S. Fulfillment
✓ Batch Verification Available View verification →
Lot Verification Variant-specific documentation
Traceable Lots VBL lot identification
Primary Literature Peer-reviewed sources
Research Use Only Laboratory research materials

Scientific Specifications

Reference characteristics for laboratory research materials.

CAS Number
885340-08-9
Molecular Formula
C38H68N10O14
Molecular Weight
889.01
Storage
-20°C
Research Classification
Research Use Only (RUO). Not for human or veterinary use.

SCIENTIFIC OVERVIEW

Scientific background and research classification for this laboratory reference material.

This catalog material is labeled TB-500. Supplied records conflict between full-length 43-residue thymosin beta-4 and the acetylated heptapeptide Ac-LKKTETQ; no disputed sequence, CAS, formula, or molecular-mass value is adopted here. Research use only.

Primary Research Category
Analytical Sciences
Material Type
Lyophilized Peptide
Intended Use
Laboratory Research
Research Categories
Identity Verification Structural Biology Analytical Chemistry

Mechanism of Action

Molecular interaction profile describing how this research material engages receptor systems and influences downstream biological signaling pathways.

No product-specific actin-binding, cell-migration, or other biological mechanism is assigned until the supplied material is independently identified. Literature for either candidate identity does not resolve the conflict.

Primary Organ Systems
  • Integumentary System

Research Documentation

Laboratory documentation is presented when available for the selected product specification and current lot.

Batch Verified
Independent Batch Verification

Independent laboratory verification for this batch:

  • Identity Confirmation
  • HPLC Purity Analysis
  • Net Peptide Content
  • Endotoxin Testing
  • Analytical Chromatogram
  • Independent Laboratory Verification
View Batch Verification →
Scientific References
Peer-Reviewed Literature

Explore published literature, clinical investigations, and foundational scientific research.

View References →
Laboratory Resources
Technical Guidance

Storage guidance, handling recommendations, analytical methods, and laboratory best practices.

Related Research
Companion Materials

Discover complementary research materials frequently studied alongside this compound.

Research Center

Scientific literature, laboratory resources, and related materials curated to support research involving this research material.

Scientific References
Peer-Reviewed Literature

Explore curated publications from peer-reviewed journals including clinical investigations, mechanistic studies, and foundational scientific literature.

Browse References →
Scientific Dossier
Deeper Technical Treatment

Comprehensive scientific documentation including literature review, mechanism, pharmacology, and study data for this research material.

Laboratory Resources
Technical Guidance

Storage guidance, handling information, analytical standards, research policies, and laboratory support documentation.

Research Library

Curated peer-reviewed literature selected to provide scientific context for this research material. Publications are grouped by the scientific identity they evidence.

TB-500 — Component Evidence

Preclinical Study•Wound Repair and Regeneration• 2003

Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice

PubMed →DOI →
Mechanistic Study•The FASEB Journal• 2003

The actin binding site on thymosin beta4 promotes angiogenesis

PubMed →DOI →
Analytical Study•Drug Testing and Analysis• 2012

Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500

PubMed →DOI →